Search Within

Jean Kyung Lee

Formats
  1. Meeting Abstract (4)
  2. Journal Article (3)
  3. Book Section (2)
Groups
  1. Department of Medicine (8)
  2. Solid Tumor Oncology Division (8)
  3. Gastrointestinal Oncology Service (7)
  4. Center for Pancreatic Cancer Research (6)
  5. Survivorship Research (4)
  6. Biostatistics Service (3)

More Groups

People
  1. Ghassan Abou-Alfa (6)
  2. Leonard Saltz (6)
  3. Eileen O'Reilly (3)
  4. James Harding (3)
  5. Joanne Chou (3)
  6. Marinela Capanu (3)

More People

Years
  1. 2016 (1)
  2. 2015 (1)
  3. 2014 (4)
  4. 2013 (3)
Publications
  1. Journal of Clinical Oncology (4)
  2. Pocket Oncology (2)
  3. British Journal of Cancer (1)
  4. Gastrointestinal Cancer Research (1)
  5. Journal of Clinical Gastroenterology (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. Wolters Kluwer Health | Lippincott Williams & Wilkins (2)
  3. International Society of Gastrointestinal Oncology (1)
  4. Lippincott Williams & Wilkins (1)
  5. Nature Publishing Group (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 study of seribantumab (MM-121) in combination with docetaxel or pemetrexed versus docetaxel or pemetrexed alone in patients with heregulin positive (HRG+), locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Sequist, L. V.; Anderson, I. C.; Demars, N.; Felip, E.; Harb, W. A.; Huber, R. M.; Kudla, A. J.; Lee, J. K.; Mathews, S.; McClure, T.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • First stage results of a phase II trial of sorafenib plus doxorubicin (SD) in patients (pts) with advanced hepatocellular carcinoma (HCC) who progressed (POD) on sorafenib (S)
    Meeting Abstract

    Abou-Alfa, G. K.; Capanu, M.; Do, R. K. G.; Hollywood, E.; Ly, M.; Chou, J. F.; Lee, J. K.; Connell, L. C.; Wan, P. J.; Bradley, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Cancer of unknown primary
    Book Section

    Lee, J. K.; Kampel, L. J.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save
  • Gastrointestinal malignancies
    Book Section

    Lee, J. K.; Abou-Alfa, G.; Harding, J. J.; O'Reilly, E. M.; Reidy-Lagunes, D.; Eng, J.; Ilson, D. H.; Janjigian, Y. Y.; Saltz, L.; Zamarin, D.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save
  • Prognostic role of C-reactive protein levels in patients with hepatocellular carcinoma undergoing sorafenib therapy
    Meeting Abstract

    Lee, J. K.; Harding, J. J.; Chou, J. F.; Capanu, M.; Saltz, L.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A 39-year-old female patient with metastatic rectal cancer develops thrombocytopenia
    Journal Article

    Dbouk, H.; Mentha, S.; Mukherji, D.; Lee, J.; Haydar, A.; Shamseddine, A.; O'Reilly, E. M.; Saltz, L.; Abou-Alfa, G. K.
    Gastrointestinal Cancer Research (2014)

    Fulltext@MSK | Save
  • Characterization of colorectal cancer (CRC) in Lynch syndrome (LS) patients with MSH6 or PMS2 mutations
    Meeting Abstract

    Lee, J. K.; Shia, J.; Rau-Murthy, R.; Corines, M.; Salo-Mullen, E. E.; Markowitz, A.; Robson, M. E.; Offit, K.; Guillem, J. G.; Saltz, L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas
    Journal Article

    Lee, J. K.; Capanu, M.; O'Reilly, E. M.; Ma, J.; Chou, J. F.; Shia, J.; Katz, S. S.; Gansukh, B.; Reidy-Lagunes, D.; Segal, N. H.; more...
    British Journal of Cancer (2013)

    Fulltext@MSK | Save
  • An update on clinical trials in the treatment of advanced hepatocellular carcinoma
    Journal Article

    Lee, J. K.; Abou-Alfa, G. K.
    Journal of Clinical Gastroenterology (2013)

    Fulltext@MSK | Save